Sanofi’s Dupixent Gains EU Approval for Pediatric Eosinophilic Esophagitis
PremiumCompany AnnouncementsSanofi’s Dupixent Gains EU Approval for Pediatric Eosinophilic Esophagitis
10d ago
Regeneron, Sanofi announce EC approval for Dupixent
Premium
The Fly
Regeneron, Sanofi announce EC approval for Dupixent
11d ago
Sanofi’s Dupixent Shows Promise for Skin Disorder
Premium
Company Announcements
Sanofi’s Dupixent Shows Promise for Skin Disorder
17d ago
Morning Movers: Capri sinks after judge blocks planned takeover by Tapestry
PremiumThe FlyMorning Movers: Capri sinks after judge blocks planned takeover by Tapestry
23d ago
Options Volatility and Implied Earnings Moves Today, October 25, 2024
Premium
Market News
Options Volatility and Implied Earnings Moves Today, October 25, 2024
23d ago
Sanofi expects FY24 business EPS growth of at least a LSD percentage at CER
Premium
The Fly
Sanofi expects FY24 business EPS growth of at least a LSD percentage at CER
23d ago
Sanofi Partners with Orano Med for Cancer Therapy
PremiumCompany AnnouncementsSanofi Partners with Orano Med for Cancer Therapy
27d ago
Sanofi (NASDAQ:SNY) Eyes Divestiture of Consumer Health Business, Opella, to U.S. Firm
Premium
Market News
Sanofi (NASDAQ:SNY) Eyes Divestiture of Consumer Health Business, Opella, to U.S. Firm
27d ago
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI, Reuters reports
Premium
The Fly
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI, Reuters reports
28d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100